Summary:
A randomized, double-blind, placebo-controlled, sequential parallel study of cerc-301 in the adjunctive treatment of subjects with depression despite antidepressant treatment.
Qualified Participants Must:
• Be between 18 and 70 years of age
•
Currently be taking antidepressant for at least the last 6 weeks
•
Be available for study visits for 7 consecutive weeks
Qualified Participants May Receive:
Study medication and research-related care provided at no cost. $50 stipend for each visit (excluding prescreen) to eligible patients.